12 reports

The goal was to demonstrate safety and efficacy of recombinant Bet v ## for desensitization against birch pollen allergy.

  • Allergy
  • Allergy Immunotherapy
  • Immunotherapy
  • Therapy
  • Anergis SA

House Dust Mite Allergy - Pipeline by Zhejiang I-Biological Technology Co Ltd, H## 2019 ZHEJIANG I-BIOLOGICAL TECHNOLOGY CO LTD House Dust Mite Allergy - Drug Profiles ALLERGAN FOR DUST MITE ALLERGY - DRUG PROFILE ALLERGEN FOR ALLERGIC ASTHMA AND HOUSE DUS

  • Allergy Immunotherapy
  • Medical Biotechnology
  • World
  • Product Initiative
  • Anergis SA

Vaccine ## for Grass Pollen Allergy - Drug Profile Vaccine for Grass Pollen Allergy - Drug Profile Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description Vaccine for Grass Pollen Allergy DC##U B

  • Allergy
  • Allergy Immunotherapy
  • Immunotherapy
  • United States
  • Product Initiative

Patients were randomized in a ##:## fashion to active drug versus placebo.

  • Allergy
  • Allergy Immunotherapy
  • Immunotherapy
  • Therapy
  • Aimmune Therapeutics, Inc.

Patients were randomized in a ##:## fashion to active drug versus placebo.

  • Allergy
  • Allergy Immunotherapy
  • Immunotherapy
  • United States
  • Product Initiative

Food and Drug Administration (FDA) has approved RAGWITEK™ (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use (## Amb a ##-U).

  • Allergy
  • Allergy Immunotherapy
  • Chronic Disease
  • Therapy
  • Biomay AG

Food and Drug Administration (FDA) has approved RAGWITEK™ (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use (## Amb a ##-U).

  • Allergy
  • Allergy Immunotherapy
  • Chronic Disease
  • United States
  • Product Initiative

Patients were randomized in a ##:## fashion to active drug versus placebo.

  • Allergy
  • Allergy Immunotherapy
  • United States
  • Product Initiative
  • Aimmune Therapeutics, Inc.

HOUSE DUST MITE ALLERGY - PIPELINE BY STALLERGENES GREER PLC, H## 2019 House Dust Mite Allergy - Drug Profiles ALLERGAN FOR DUST MITE ALLERGY - DRUG PROFILE ALLERGEN FOR ALLERGIC ASTHMA AND HOUSE DUST MITE ALLERGY - DRUG PROFILE AM-## -

  • Allergy Immunotherapy
  • Medical Biotechnology
  • United States
  • World
  • Product Initiative

HALMRE-## - DRUG PROFILE POLLINEX QUATTRO GRASS - DRUG PROFILE Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description Pollinex Quattro Grass Allergy Therapeutics Plc NA GlaxoSmithKline Plc R& D Progress Resea

  • Allergy Drug
  • Allergy Immunotherapy
  • Ophthalmic Solution
  • Pharmaceutical
  • Product Initiative

The drug candidate activates allergen-specific T-helper type ## (Th##) cellular responses with the production of interferons by antigen presenting cells (APC), natural killer cells (NK), and T cells.

  • Allergy Drug
  • Allergy Immunotherapy
  • Ophthalmic Solution
  • Pharmaceutical
  • Allergy Therapeutics plc

THE DRUG CANDIDATE IS A MUTANT DERIVATIVE BIRCH POLLEN ALLERGEN BET V ##.

  • Allergy Drug
  • Allergy Immunotherapy
  • Respiratory Disease
  • Therapy
  • Product Initiative